Prosthetic valve endocarditis.
Prosthetic valve endocarditis is a catastrophic complication of cardiac valve replacement, associated with high mortality rates. Medical treatment is effective in a few instances of endocarditis involving the leaflets alone in bioprostheses. However, accurate diagnosis, better myocardial protection, and improved surgical strategies have led to better survival in patients undergoing surgery after failed conservative therapy. This comprehensive review addresses various issues involved in the management of this complication.
Mahesh
Balakrishnan
B
Cardiothoracic Center, Bristol Royal Infirmary, Bristol, United Kingdom. b.mahesh@imperial.ac.uk
Angelini
Gianni
G
Caputo
Massimo
M
Jin
Xu Yu
XY
Bryan
Alan
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001705:Bioprosthesis / Q000382:microbiology; D006348:Cardiac Surgical Procedures / Q000379:methods; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D004867:Equipment Design; D006350:Heart Valve Prosthesis / Q000009:adverse effects* / Q000382:microbiology; D006801:Humans; D011379:Prognosis; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents